NeuroPace, Inc. NPCE
NASDAQ · United States · Health Technology
$12.70-0.45 (-3.42%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.18 | -0.22 | +17.4% | $22.83M | +0.9% | -2.2%$14.88→$14.56 |
| Q1 2026 | 2026-05-12 | -0.13 | -0.19 | +31.6% | — | — | +0.9%$15.67→$15.81 |
| Q4 2025 | 2026-03-03 | -0.08 | -0.15 | +46.7% | — | — | -1.4%$14.15→$13.95 |
| Q3 2025 | 2025-11-04 | -0.11 | -0.20 | +45.0% | — | — | +38.1%$9.40→$12.98 |
| Q4 2024 | 2025-03-04 | -0.18 | -0.22 | +18.2% | — | — | — |
| Q4 2023 | 2024-03-05 | -0.23 | -0.32 | +28.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.